文献速递垂体与肾上腺疾病性腺与生殖内分泌

21-羟化酶缺陷所致经典型先天性肾上腺皮质增生症青少年及成年女性的临床表现与管理挑战

Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

本文综述21-羟化酶缺陷所致经典型先天性肾上腺皮质增生症青少年及成年女性的临床表现与管理挑战。患者需终身糖皮质激素治疗以替代皮质醇缺乏并减少肾上腺雄激素过多,治疗不足或过度均可导致生长受损、月经紊乱、生育力下降及心血管代谢并发症。文章为医疗专业人员提供指导,帮助患者应对青春期过渡至成年期的管理难题。

要点

  • 经典型先天性肾上腺皮质增生症患者需终身糖皮质激素治疗,治疗不足或过度均可导致多种疾病和治疗相关并发症。
  • 青少年女性治疗目标包括获得正常生长和骨成熟、正常青春期时序,同时避免肾上腺危象和猝死。
  • 过渡至成人期治疗重点为预防高雄激素症状、维持月经规律和生育力,并持续监测骨密度、肥胖、糖尿病和高血压等长期并发症。

核心结论

  • 经典型先天性肾上腺皮质增生症的管理仍具挑战性,需平衡糖皮质激素治疗以避免治疗不足或过度带来的并发症。
  • 青少年及成年女性患者面临生长、青春期、月经、生育力及心血管代谢等多方面问题,需持续监测和个体化管理。

研究设计与样本

  • 本文为综述,讨论青少年及成年女性经典型先天性肾上腺皮质增生症的临床表现与管理挑战,并为医疗专业人员提供指导。

主要发现

  • 经典型先天性肾上腺皮质增生症由21-羟化酶缺陷导致皮质醇缺乏和肾上腺雄激素过多。
  • 新生儿筛查降低了患病率和死亡率,但管理仍具挑战性。
  • 糖皮质激素治疗不足或过度可导致生长受损和最终身高受影响、女性月经紊乱和生育力下降以及长期心血管代谢并发症。
  • 青少年期生长和性激素水平变化可导致肾上腺雄激素抑制不足,且独立性增加可影响治疗依从性。

关键数值与推荐

  • 治疗目标包括避免肾上腺危象和猝死,获得正常生长和骨成熟以及正常青春期时序。
  • 过渡至成人期治疗目标包括预防高雄激素症状、保持月经规律和生育力,并提供性健康、非典型生殖器和既往手术并发症相关的教育和支持。
  • 需持续监测以预防骨密度降低、肥胖、糖尿病和高血压等长期并发症。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is a rare genetic condition that results in cortisol deficiency and excess production of adrenal androgens. While the introduction of newborn screening for CAH has reduced morbidity and mortality, management of CAH remains challenging. Lifelong treatment with glucocorticoids is required to replace the endogenous cortisol deficiency and reduce excess adrenal androgens. Undertreatment or overtreatment with glucocorticoids can lead to multiple disease- and treatment-related comorbidities, including impaired growth and compromised final height, menstrual irregularities and reduced fertility in females, and long-term cardiometabolic complications. In addition to avoiding adrenal crisis and sudden death, treatment goals in adolescent females with CAH are to obtain normal growth and bone maturation and normal timing of puberty. Management of adolescents is particularly challenging due to changes in growth and sex hormone levels that can lead to inadequate suppression of adrenal androgens and increasing independence that can affect treatment adherence. During the transition to adult care, treatment goals focus on preventing symptoms of hyperandrogenism, preserving menstrual regularity and fertility, and providing education and support for issues related to sexuality, atypical genitalia, and/or complications from previous surgical treatment. In addition, patients must be monitored continuously to prevent long-term complications such as decreased bone mineral density, obesity, diabetes, and hypertension. In this review, we discuss the challenges faced by adolescent and adult females with CAH and provide guidance to health-care professionals to help patients to navigate these challenges.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Engberg H, Nordenström A, Hirschberg AL, et al. Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2025. PMID: 39836618. doi:10.1210/clinem/dgae696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。